
Dameron Levest Jones
Examiner (ID: 18762, Phone: (571)272-0617 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1621, 1616, 3991, 1211, 1618, RD00, 1619, 1622, 1615 |
| Total Applications | 2574 |
| Issued Applications | 1523 |
| Pending Applications | 392 |
| Abandoned Applications | 685 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13490323
[patent_doc_number] => 20180296704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => Solid Cyanine Dyes
[patent_app_type] => utility
[patent_app_number] => 15/951911
[patent_app_country] => US
[patent_app_date] => 2018-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15951911
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/951911 | Solid cyanine dyes | Apr 11, 2018 | Issued |
Array
(
[id] => 13397765
[patent_doc_number] => 20180250425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => TRIFUNCTIONAL AND COMPLETELY CLEARABLE SPECIFIC TARGETING AGENTS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/939230
[patent_app_country] => US
[patent_app_date] => 2018-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15939230
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/939230 | Trifunctional and completely clearable specific targeting agents and methods thereof | Mar 27, 2018 | Issued |
Array
(
[id] => 14156593
[patent_doc_number] => 20190105399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => Vitamin-Receptor Binding Drug Delivery Conjugates
[patent_app_type] => utility
[patent_app_number] => 15/936393
[patent_app_country] => US
[patent_app_date] => 2018-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22545
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15936393
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/936393 | Vitamin-Receptor Binding Drug Delivery Conjugates | Mar 25, 2018 | Abandoned |
Array
(
[id] => 14156593
[patent_doc_number] => 20190105399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => Vitamin-Receptor Binding Drug Delivery Conjugates
[patent_app_type] => utility
[patent_app_number] => 15/936393
[patent_app_country] => US
[patent_app_date] => 2018-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22545
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15936393
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/936393 | Vitamin-Receptor Binding Drug Delivery Conjugates | Mar 25, 2018 | Abandoned |
Array
(
[id] => 17527960
[patent_doc_number] => 11300640
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-12
[patent_title] => Protein reporters for ultrasensitive detection methods
[patent_app_type] => utility
[patent_app_number] => 15/919566
[patent_app_country] => US
[patent_app_date] => 2018-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 65
[patent_no_of_words] => 41668
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15919566
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/919566 | Protein reporters for ultrasensitive detection methods | Mar 12, 2018 | Issued |
Array
(
[id] => 12908662
[patent_doc_number] => 20180194729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => 18F - TAGGED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AND THEIR USE AS IMAGING AGENTS FOR PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 15/915978
[patent_app_country] => US
[patent_app_date] => 2018-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9337
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 246
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15915978
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/915978 | 18F--tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer | Mar 7, 2018 | Issued |
Array
(
[id] => 15345233
[patent_doc_number] => 20200010508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => Glypican-3 Peptide Reagents and Methods
[patent_app_type] => utility
[patent_app_number] => 16/491117
[patent_app_country] => US
[patent_app_date] => 2018-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14249
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16491117
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/491117 | Glypican-3 peptide reagents and methods | Mar 6, 2018 | Issued |
Array
(
[id] => 15361037
[patent_doc_number] => 20200016283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => COMBINATION THERAPY COMPRISING A RADIOPHARMACEUTICAL AND A DNA-REPAIR INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 16/488158
[patent_app_country] => US
[patent_app_date] => 2018-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10027
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488158
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/488158 | COMBINATION THERAPY COMPRISING A RADIOPHARMACEUTICAL AND A DNA-REPAIR INHIBITOR | Feb 21, 2018 | Abandoned |
Array
(
[id] => 16604800
[patent_doc_number] => 10905784
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-02
[patent_title] => Radiolabeled anti-LAG3 antibodies for immuno-PET imaging
[patent_app_type] => utility
[patent_app_number] => 15/892440
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 28885
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15892440
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/892440 | Radiolabeled anti-LAG3 antibodies for immuno-PET imaging | Feb 8, 2018 | Issued |
Array
(
[id] => 16465941
[patent_doc_number] => 20200367478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => METHOD FOR ESTABLISHING ULCERATIVE COLITIS ANIMAL MODEL AND USE OF SAID MODEL
[patent_app_type] => utility
[patent_app_number] => 16/463578
[patent_app_country] => US
[patent_app_date] => 2018-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16463578
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/463578 | METHOD FOR ESTABLISHING ULCERATIVE COLITIS ANIMAL MODEL AND USE OF SAID MODEL | Feb 7, 2018 | Abandoned |
Array
(
[id] => 12817420
[patent_doc_number] => 20180164312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => 4,4-DISUBSTITUTED CYCLOHEXYL BRIDGED HEPTAMETHINE CYANINE DYES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/890646
[patent_app_country] => US
[patent_app_date] => 2018-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14021
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15890646
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/890646 | 4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof | Feb 6, 2018 | Issued |
Array
(
[id] => 15243347
[patent_doc_number] => 10507183
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-17
[patent_title] => Cleavable lipids
[patent_app_type] => utility
[patent_app_number] => 15/887693
[patent_app_country] => US
[patent_app_date] => 2018-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 25811
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15887693
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/887693 | Cleavable lipids | Feb 1, 2018 | Issued |
Array
(
[id] => 15145203
[patent_doc_number] => 20190351079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => COMPOSITIONS AND METHODS FOR CANCER IMAGING AND RADIOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 16/479234
[patent_app_country] => US
[patent_app_date] => 2018-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16479234
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/479234 | Compositions and methods for cancer imaging and radiotherapy | Jan 29, 2018 | Issued |
Array
(
[id] => 12766012
[patent_doc_number] => 20180147172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => Compositions for Mitigating Head Trauma
[patent_app_type] => utility
[patent_app_number] => 15/878288
[patent_app_country] => US
[patent_app_date] => 2018-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3363
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15878288
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/878288 | Compositions for Mitigating Head Trauma | Jan 22, 2018 | Abandoned |
Array
(
[id] => 15206481
[patent_doc_number] => 20190365927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => COMPOSITION FOR PHOTODYNAMIC THERAPY USING GENE EXPRESSING FLUORESCENT PROTEIN AND PHOTOSENSITIZER, AND PHOTODYNAMIC THERAPY METHOD USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/478175
[patent_app_country] => US
[patent_app_date] => 2018-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16478175
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/478175 | COMPOSITION FOR PHOTODYNAMIC THERAPY USING GENE EXPRESSING FLUORESCENT PROTEIN AND PHOTOSENSITIZER, AND PHOTODYNAMIC THERAPY METHOD USING SAME | Jan 15, 2018 | Abandoned |
Array
(
[id] => 15083625
[patent_doc_number] => 20190336623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => TREATMENT OF CANCER CELLS OVEREXPRESSING SOMATOSTATIN RECEPTORS USING OCREOTIDE DERIVATIVES CHELATED TO RADIOISOTOPES
[patent_app_type] => utility
[patent_app_number] => 16/477623
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16477623
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/477623 | Treatment of cancer cells overexpressing somatostatin receptors using ocreotide derivatives chelated to radioisotopes | Jan 11, 2018 | Issued |
Array
(
[id] => 16784967
[patent_doc_number] => 10987366
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-27
[patent_title] => Methods and compositions for protection of cells and tissues from computed tomography radiation
[patent_app_type] => utility
[patent_app_number] => 15/862171
[patent_app_country] => US
[patent_app_date] => 2018-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10111
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15862171
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/862171 | Methods and compositions for protection of cells and tissues from computed tomography radiation | Jan 3, 2018 | Issued |
Array
(
[id] => 15797343
[patent_doc_number] => 20200121814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => HER3 Peptides for Imaging and Radiotherapy
[patent_app_type] => utility
[patent_app_number] => 16/475020
[patent_app_country] => US
[patent_app_date] => 2017-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15485
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 294
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16475020
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/475020 | HER3 peptides for imaging and radiotherapy | Dec 28, 2017 | Issued |
Array
(
[id] => 18574313
[patent_doc_number] => 11730819
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Peptide derivatives having novel linkage structures
[patent_app_type] => utility
[patent_app_number] => 16/472242
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 21
[patent_no_of_words] => 16747
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16472242
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/472242 | Peptide derivatives having novel linkage structures | Dec 19, 2017 | Issued |
Array
(
[id] => 13297705
[patent_doc_number] => 20180200389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => PHOTOACOUSTIC VOLTAGE-SENSITIVE DYES FOR IN VIVO IMAGING
[patent_app_type] => utility
[patent_app_number] => 15/837891
[patent_app_country] => US
[patent_app_date] => 2017-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25989
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15837891
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/837891 | PHOTOACOUSTIC VOLTAGE-SENSITIVE DYES FOR IN VIVO IMAGING | Dec 10, 2017 | Abandoned |